These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 190276)

  • 21. Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
    Zhuplatov SB; Masaki T; Blumenthal DK; Cheung AK
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):431-9. PubMed ID: 17169124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic stimulation of DNA synthesis by cyclic AMP derivatives and growth factors in mouse 3T3 cells.
    Rozengurt E
    J Cell Physiol; 1982 Aug; 112(2):243-50. PubMed ID: 6288743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthines, papaverine, and cyclic nucleotides.
    Wells JN; Wu YJ; Baird CE; Hardman JG
    Mol Pharmacol; 1975 Nov; 11(6):775-83. PubMed ID: 173982
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the effect of theophylline and cyclic adenosine 3': 5'-monophosphate on the superior cervical ganglion of the rabbit by means of the sucrose-gap method.
    Dun NJ; Karczmar AG
    J Pharmacol Exp Ther; 1977 Jul; 202(1):89-96. PubMed ID: 195038
    [No Abstract]   [Full Text] [Related]  

  • 26. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB; Wilkinson RG
    Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
    Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M
    Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro response of goldfish (Carassius auratus L.) dermal melanophores to cyclic 3',5'-nucleotides, nucleoside 5'-phosphates and methylxanthines.
    Abramowitz J; Chavin W
    J Cell Physiol; 1974 Oct; 84(2):301-9. PubMed ID: 4373483
    [No Abstract]   [Full Text] [Related]  

  • 30. A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase.
    Hung SH; Madhusoodanan KS; Beres JA; Boyd RL; Baldwin JL; Zhang W; Colman RW; Colman RF
    Bioorg Chem; 2002 Feb; 30(1):16-31. PubMed ID: 11955000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.
    Barreto EO; Carvalho VF; Lagente V; Lugnier C; Cordeiro RS; Martins MA; E Silva PM
    Int Immunopharmacol; 2004 Jun; 4(6):755-62. PubMed ID: 15135317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.
    Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
    J Immunol; 1991 Apr; 146(8):2712-8. PubMed ID: 1707917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL; Garst JE; Mitchel SS; Wells JN
    Biochemistry; 1977 Jul; 16(15):3316-21. PubMed ID: 196632
    [No Abstract]   [Full Text] [Related]  

  • 34. Imbalanced cyclic AMP-cyclic GMP levels in psoriasis.
    Voorhees JJ; Duell EA
    Adv Cyclic Nucleotide Res; 1975; 5():735-58. PubMed ID: 165696
    [No Abstract]   [Full Text] [Related]  

  • 35. PDE4 inhibitors: new xanthine analogues.
    Montana JG; Cooper N; Dyke HJ; Gowers L; Gregory JP; Hellewell PG; Miotla J; Morris K; Naylor R; Tuladhar B; Warneck JB
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2925-30. PubMed ID: 9873649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine 3',5'-phosphate phosphodiesterase and pheromone response in the yeast Saccharomyces cerevisiae.
    Liao HH; Thorner J
    J Bacteriol; 1981 Dec; 148(3):919-25. PubMed ID: 6171560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human prostatic epithelial cell replication by cAMP and selected analogs.
    Niles RM; Makarski JS; Kurtz MJ; Rutenburg AM
    Exp Cell Res; 1976 Oct; 102(1):95-103. PubMed ID: 185073
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic AMP and cyclic GMP enhance growth of chick embryo fibroblasts.
    Hovi T; Vaheri A
    Nat New Biol; 1973 Oct; 245(145):175-7. PubMed ID: 4355102
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Francis DL; Roy AC; Collier HO
    Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452
    [No Abstract]   [Full Text] [Related]  

  • 40. Caffeine and related methylxanthines: possible naturally occurring pesticides.
    Nathanson JA
    Science; 1984 Oct; 226(4671):184-7. PubMed ID: 6207592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.